27th February, 2025
Hadfield succeeds Dr. Ralph Highnam, who transitions to Chief Science & Innovation Officer, as Volpara accelerates global growth in AI-driven cancer detection and prevention.
Craig Hadfield, newly appointed CEO of Volpara (Courtesy of Lunit)
Lunit (KRX: 328130) has announced the appointment of Craig Hadfield as the new CEO of Volpara Health, effective April 1, 2025. Hadfield, currently CFO of Volpara, succeeds Dr. Ralph Highnam, who will transition to Chief Science & Innovation Officer and continue as an Executive Director on the Board.
With over 25 years of financial and operational experience, Hadfield has been instrumental in Volpara’s global expansion and strategic growth. His leadership aims to strengthen Volpara’s position in AI-powered cancer detection and prevention.
“Craig’s expertise and deep understanding of Volpara’s mission make him the ideal leader for our next growth phase,” said Brandon Suh, CEO of Lunit.
The transition aligns with Lunit’s commitment to advancing AI-driven healthcare solutions, reinforcing Volpara’s global impact in early cancer detection and imaging innovation.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
Asia Pacific
Global / International
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer